Evidence map›Paper›PMID 24723474›Full record

ArticleThe Journal of infectious diseases2014

Return of widespread chloroquine-sensitive Plasmodium falciparum to Malawi.

Anne E P Frosch, Miriam K Laufer, Don P Mathanga, Shannon Takala-Harrison, Jacek Skarbinski, Cassidy W Claassen, Fraction K Dzinjalamala, Christopher V Plowe

Abstract read
In one paragraph

Article in The Journal of infectious diseases, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 65 papers.

0numbers the graph read from it
0cells of the map it votes in
65citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

65 citing papers in PubMed.

  1. Revisiting Co-trimoxazole Prophylaxis for African Adults in the Era of Antiretroviral Therapy: A Randomized Controlled Clinical Trial.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2021
    Trial
  2. Changing Antimalarial Drug Sensitivities in Uganda.Antimicrobial agents and chemotherapy · 2017
    Trial
  3. Trial
  4. Trial
  5. Trial
  6. Towards an evolutionary baseline model ofbioRxiv : the preprint server for biology · 2025
    Article
  7. Review
  8. Plasmodium falciparum isolates: ex vivo drug response.The Journal of antimicrobial chemotherapy · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Polymorphism of Drug Resistance GenesTropical medicine and infectious disease · 2023
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

5 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Anne E P FroschHoward Hughes Medical Institute/Center for Vaccine Development, University of Maryland School of Medicine, Baltimore Department of Medicine, University of Minnesota, Minneapolis.
Miriam K LauferHoward Hughes Medical Institute/Center for Vaccine Development, University of Maryland School of Medicine, Baltimore.
Don P MathangaMalaria Alert Center.
Shannon Takala-HarrisonHoward Hughes Medical Institute/Center for Vaccine Development, University of Maryland School of Medicine, Baltimore.
Jacek SkarbinskiMalaria Branch, Centers for Disease Control and Prevention, Atlanta, Georgia.
Cassidy W ClaassenHoward Hughes Medical Institute/Center for Vaccine Development, University of Maryland School of Medicine, Baltimore.
Fraction K DzinjalamalaDepartment of Pharmacology, University of Malawi College of Medicine, Blantyre.
Christopher V PloweHoward Hughes Medical Institute/Center for Vaccine Development, University of Maryland School of Medicine, Baltimore.

Funding

Genome-wide studies to identify markers of artemisinin-resistant malariaR01AI101713 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI HARRISON, SHANNON TAKALA · 2013 to 2016
$1.8M
Howard Hughes Medical InstituteNCPDCID CDC HHS U01 CI000189NIAID NIH HHS R01 AI101713
6 · The paper itself

Abstract

backgroundThe return of chloroquine-sensitive Plasmodium falciparum to the limited area of Blantyre, Malawi, has been well demonstrated in several studies.

methodsTo characterize chloroquine susceptibility over a wide geographic area, infants and children aged 6-59 months were selected using 2-stage cluster sampling in 8 Malawian districts. Pyrosequencing of the pfcrt gene codon 76 region was performed for children with asexual parasitemia.

resultsOf 7145 children, 1150 had microscopic asexual parasitemia, and sequencing was performed in 685, of whom 1 had a chloroquine-resistant genotype.

conclusionsSystematic countrywide sampling demonstrates that the chloroquine pfcrt genotype has reached near-fixation, raising the possibility of reintroducing chloroquine for malaria prevention and treatment.

Indexed as

AntimalarialsChild, PreschoolChloroquineCross-Sectional StudiesGenotypeGenotyping TechniquesHumansInfantMalaria, FalciparumMalawiMaleMembrane Transport ProteinsParasitic Sensitivity TestsPlasmodium falciparumProtozoan ProteinsSequence Analysis, DNAAntimalarialsChloroquineMembrane Transport ProteinsPfCRT protein, Plasmodium falciparumProtozoan ProteinsAfricachloroquinemalariaMalawiPfCRTPlasmodium falciparumresistance

Identifiers

PMID24723474
PMCPMC6281358

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.